To examine whether combination therapy could relieve immune suppression and stimulate a specific immune response, a cytotoxic T lymphocyte (CTL) assay of splenocytes was performed against UN-KC-6141 or ALTS1C1 (murine astrocytoma) targets [44]. The gene discussed is CALCA; the disease is astrocytoma (excluding glioblastoma).